Breaking News

Bora Pharmaceuticals Acquires CDMO Assets from Eden Biologics

Establishes leadership position in Taiwan's CDMO sector and plans to expand into the global CDMO market.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Taiwan-based international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the establishment of Bora Biologics Co., Ltd., to focus on the development of bio-pharmaceuticals. Bora Biologics has investors Taishin Healthcare Limited Partnership and Dr. Allen Chao, founder of Tanvex BioPharma to support the growth and strategy in bio-pharmaceuticals. With Bora’s strengths as a CDMO for small molecules and biological macromolecules, the company...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters